Literature DB >> 15903121

The importance of assessing the dose actually administered in pharmacokinetic trials.

Thierry Buclin1, Nancy Perrottet, Jerome Biollaz.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15903121     DOI： 10.1016/j.clpt.2004.11.006

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  2 in total

1.  Effect of dronedarone on renal function in healthy subjects.

Authors:  Yvonne Tschuppert; Thierry Buclin; Laura E Rothuizen; Laurent A Decosterd; Jacques Galleyrand; Christine Gaud; Jérôme Biollaz
Journal:  Br J Clin Pharmacol       Date:  2007-07-27       Impact factor: 4.335

2.  Biases affecting injected doses of an experimental drug during clinical trials.

Authors:  Nancy Perrottet; Françoise Brunner-Ferber; Eric Grouzmann; François Spertini; Jérôme Biollaz; Thierry Buclin; Nicolas Widmer
Journal:  Trials       Date:  2016-07-16       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.